The emergence of plasmid-mediated colistin resistance, primarily driven by the mcr-1 gene, represents a major global health threat. IncI2 plasmids, one of the leading carriers of mcr-1, have been frequently recovered from clinical and agricultural settings. However, their persistence in the absence of antibiotic pressure and adaptive responses to colistin exposure remain poorly understood. We conducted 60-day laboratory evolution experiments using Escherichia coli C600 carrying the mcr-1-harboring IncI2 plasmid pBD110 under three colistin concentrations (0, 2, and 4 mg/L). Stability was evaluated using polymerase chain reaction (PCR). Bacterial fitness was assessed using growth curve analysis and competition assays. Antimicrobial susceptibility was determined by the broth microdilution method. Conjugation potential was examined using conjugation experiments. Genomic alterations were investigated using whole-genome sequencing combined with bioinformatic analysis. pBD110 was stably maintained for 120 passages under all conditions, with no significant loss observed in the absence of colistin. Under strong selection (4 mg/L), plasmid abundance increased, whereas moderate pressure (2 mg/L) led to fitness costs and reduced plasmid copy number. Whole-genome sequencing revealed distinct adaptive strategies: plasmids under non-selective conditions accumulated mutations in conjugation-related genes, enhancing transfer frequency, whereas those under colistin exposure retained structural stability but acquired shufflon inversions that impaired conjugation. Host genomes accumulated numerous chromosomal mutations, particularly in metabolic and stress response pathways, to compensate for resistance-associated burdens. IncI2 plasmids exhibit dual evolutionary strategies. In the absence of colistin, they optimized horizontal transfer, whereas under selective pressure, they prioritized the stability and vertical inheritance of mcr-1. These findings provide new insights into the persistence and dissemination of colistin resistance and highlight evolutionary trade-offs that shape plasmid-host coadaptation.
3 June 2026 in Antimicrobial Agents and Chemotherapy
The global spread of plasmid-mediated colistin resistance gene mcr-1 poses a significant threat to public health. Although international travel is a known driver of antimicrobial resistance, the role of domestic travel in high-prevalence settings remains unclear. We conducted a prospective cohort study of 81 healthy volunteers traveling in China (June–September 2022). Fecal samples collected before and after travel were screened for mcr-1 -positive Escherichia coli (MCRPEC). Antimicrobial resistance genes (ARGs), virulence factors (VFs), plasmid replicons, and gut microbial dynamics were investigated using whole-genome sequencing and 16S rRNA sequencing. Risk factors were analyzed using logistic regression analysis. Of the 81 participants who were negative for mcr-1 at baseline, 12 (14.8%) acquired mcr-1 after travel. Acquisition was associated with residence near poultry farms (odds ratio [OR] = 5.9, P = 0.04) and diarrhea during travel (OR = 11.22, P = 0.027). MCRPEC exhibited marked genetic diversity comprising 10 sequence types and the carriage of additional 23 ARGs and nine adherence-associated VFs. mcr-1 was located on IncI2, IncX4, IncHI2, or IncP plasmids, with 91.7% ( n = 11) transferable in conjugation assays. Gut microbiome analysis showed increased α -diversity, but a stable community structure, indicating colonization without major disruption. Our study demonstrated that domestic travel in China substantially contributes to the dissemination of mcr-1 . Poultry exposure and gastrointestinal disturbances are key risk factors. Genetic diversity, plasmid transferability, and co-carriage of resistance and virulence determinants highlight the risk of onward spread. Antimicrobial resistance surveillance should extend beyond international travel and incorporate domestic mobility within a “One Health” framework.
The plasmid-borne mcr-1 gene poses a significant threat to global health by conferring resistance to colistin, a critical last-resort antibiotic. While its spread is well documented, the adaptations enabling its concurrent antibiotic resistance and clinical pathogenicity remain unknown. The metabolism of bacterial pathogens has evolved to support virulence in nutrient-limiting host environments. Here, we show that sorbose metabolism promotes the fitness and virulence of mcr-1- positive Escherichia coli (MCRPEC), but does not affect its resistance to colistin or polymyxin B. Notably, the virulence contribution is also observed in an mcr-1 -negative background. Genetic disruption of sorbose catabolism (Δ sorD ) attenuated MCRPEC virulence and fitness both in vitro and in vivo . Integrated transcriptomic and metabolomic analyses suggest that this attenuation is associated with impaired expression of two major virulence determinants. First, defective sorbose metabolism limits the supply of monosaccharide precursors required for LPS biosynthesis, leading to reduced LPS content. Second, metabolic disruption decreases intracellular cAMP levels, which downregulates fimH expression via a cAMP-dependent signaling pathway, thereby compromising bacterial adhesion. Notably, although sorD deletion enhances biofilm formation, this increase is insufficient to rescue the in vivo virulence defect. Restoration of the sorbose metabolic pathway partially rescues MCRPEC pathogenicity. These findings suggest that sorbose metabolism contributes to MCRPEC pathogenicity by supporting LPS synthesis and regulating fimH expression via cAMP signaling. This study indicates a metabolic link between sorbose utilization and MCRPEC pathogenicity, raising the possibility that sorbose, a common food additive, could facilitate MCRPEC pathogenicity. IMPORTANCE: The spread of colistin-resistant Escherichia coli ( E. coli ) limits treatment options for life-threatening infections. This study shows that sorbose metabolism, which utilizes a common dietary sugar, contributes to the fitness and virulence of such resistant bacteria without affecting their colistin resistance. Using mcr-1 -positive E. coli , we find that this metabolic pathway supports lipopolysaccharide synthesis and, via a cAMP-dependent mechanism, promotes bacterial adhesion. Disabling sorbose catabolism attenuates the pathogen in animal models. These findings suggest a previously unrecognized link between a specific carbohydrate metabolism and pathogenesis in drug-resistant E. coli , raising the possibility that dietary components may influence infection outcomes.